Illinois 2025-2026 Regular Session

Illinois House Bill HB3662

Introduced
2/7/25  
Refer
2/18/25  
Refer
3/11/25  
Report Pass
3/20/25  
Engrossed
4/9/25  
Refer
4/10/25  
Refer
5/8/25  
Report Pass
5/15/25  

Caption

JAIL RELEASE-OPIOID ANTAGONIST

Impact

If passed, HB3662 would alter existing state protocols regarding the management of opioid overdose prevention. It includes stipulations for training correctional facility staff on the proper administration of opioid antagonists and on educating released individuals about the drug’s usage and overdose prevention strategies. This legislative effort seeks to integrate additional layers of support within the justice system to aid individuals battling opioid addiction, thereby enhancing public health responses to substance abuse issues.

Summary

House Bill 3662, titled 'JAIL RELEASE-OPIOID ANTAGONIST,' aims to address the rising concern over opioid-related incidents in Illinois by mandating the provision of opioid antagonists, such as naloxone, to individuals upon their release from correctional facilities. The bill is part of a larger strategy to combat the opioid crisis by ensuring that individuals have immediate access to potentially lifesaving medication that can reverse the effects of opioid overdoses. This initiative is intended to reduce the rate of opioid-related deaths following incarceration, a critical concern given the link between release from custody and increased overdose risk.

Sentiment

The sentiment around HB3662 appears largely positive among public health advocates, substance abuse prevention groups, and certain legislative leaders who view it as a proactive measure against a devastating public health crisis. Supporters argue that providing opioid antagonists upon release is a crucial step in mitigating overdose risks, emphasizing the importance of transitional care and addiction support for those re-entering the community. However, there may be concerns among some lawmakers about the financial implications of the bill and the efficacy of such measures in truly curbing the opioid crisis.

Contention

Notable points of contention include the adequacy of training for facility staff, the logistics of distribution of opioid antagonists, and the potential stigma that may accompany the provision of medication to individuals post-incarceration. Critics may argue that while the intentions are commendable, without comprehensive support systems and funding, the bill may not achieve its desired outcomes. Additionally, the balance between health measures and criminal justice considerations will be a core focus during discussions about this bill's implementation.

Companion Bills

No companion bills found.

Previously Filed As

IL HB5527

JAIL RELEASE-OPIOID ANTAGONIST

IL SB3779

SOCIAL WORK-OPIOID ANTAGONIST

IL HB5529

SOCIAL WORK-OPIOID ANTAGONIST

IL HB3926

SCH CD-OPIOID ANTAGONIST

IL HB3428

SCH CD-OPIOID ANTAGONIST

IL SB3979

TIF-ST. CHARLES

IL SB1391

TIF/REDEVELOPMENT PROJECT AREA

IL SB3515

TIF EXTENSION RESTRICTIONS

IL SB2202

TIF-CITY OF SPARTA

IL SB1783

TIF-CITY OF PEORIA

Similar Bills

IL SB2008

GROCERY INITIATIVE-OWNER

IL HB0022

CROHNS AND COLITIS AWARENESS

IL SB1989

BLOOMINGTON-TREATED WASTEWATER

IL HR0319

COMMEND-ANDREW STEIN

IL HB3187

DCEO-VARIOUS

IL HB1189

PREVAILING WAGE-FED PROJECT

IL HB1830

SCH-PROFESSIONAL REVIEW PANEL

IL HB2488

OCCUPATIONAL SAFETY-PENALTY